Edd Fleming - Executive Vice President, Commercialization @ Enavate Sciences

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

200,396

Primary Job Title Executive Vice President, Commercialization
Primary Organization
Enavate Sciences

Location Palo Alto, California, United States
Regions San Francisco Bay Area, Silicon Valley, West Coast
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Edd Fleming is the Executive Vice President, Commercialization of Enavate Sciences. He previously worked at McKinsey & Company as a Senior Partner. Edd Fleming attended Harvard University.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	OrsoBio	Enavate Sciences	—	Series B - OrsoBio	obfuscated obfuscation
obfuscated obfuscation	Sionna Therapeutics	Enavate Sciences	Yes	Series C - Sionna Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Sudo Biosciences	Enavate Sciences	Yes	Series B - Sudo Biosciences	obfuscated obfuscation
obfuscated obfuscation	Sudo Biosciences	Enavate Sciences	Yes	Series B - Sudo Biosciences	obfuscated obfuscation
obfuscated obfuscation	OrsoBio	Enavate Sciences	Yes	Series A - OrsoBio	obfuscated obfuscation
obfuscated obfuscation	Upstream Bio	Enavate Sciences	Yes	Series B - Upstream Bio	obfuscated obfuscation

Jobs

Number of Current Jobs

Edd Fleming

is the

Executive Vice President, Commercialization

Enavate Sciences

Enavate Sciences Executive Vice President, CommercializationNov 2022

Board and Advisor Roles

Number of Current Board & Advisor Roles

Edd Fleming

holds

board and advisor roles including

Board Member

Sionna Therapeutics

Board Member

OrsoBio

, and

Board Member

Egnite

Sionna Therapeutics Board MemberMar 6, 2024
OrsoBio Board MemberNov 2023
Egnite Board MemberOct 2022
McKinsey & Company Senior AdvisorSep 2022
Komodo Health Board MemberOct 2021
CRISPR Therapeutics Board MemberJul 2021
Sudo Biosciences Board Member
Upstream Bio Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Post IPO Investors with Investments in Western US	24,016
United States Health Care Companies with Private Equity Funding	30,536
Early Stage Venture Investors with Investments in Palo Alto, California	9,061
Health Care Private Equity Stage Companies With Fewer Than 100 Employees	49,529
Private Equity Firms with Investments in Palo Alto, California	34,601
Private Equity Firms with Investments in Silicon Valley	7,721
Post IPO Investors with Investments in San Francisco Bay Area	28,455
Post IPO Investors with Investments in Palo Alto, California	52,477
Medical Private Equity Stage Companies With Fewer Than 1000 Employees	59,315
Late Stage Venture Investors with Investments in Silicon Valley	4,187

Education

Edd Fleming

studied at

Harvard University

and

Vanderbilt University School of Medicine

Harvard University BAChemistry19801984
Vanderbilt University School of Medicine Doctor of MedicineAug 1985May 1989

Recent News and Activity

There is no recent news or activity for this profile.